[1]蔡薇 杨堰焯 刘昊凌.甘油三酯葡萄糖乘积指数与糖尿病血管病变的研究进展[J].心血管病学进展,2022,(3):245-248.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
　CAI Wei,YANG Yanzhuo,LIU Haoling.Triglyceride-Glucose Index and Diabetic Vascular Disease[J].Advances in Cardiovascular Diseases,2022,(3):245-248.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
点击复制

甘油三酯葡萄糖乘积指数与糖尿病血管病变的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年3期
页码:
245-248
栏目:
综述
出版日期:
2022-03-25

文章信息/Info

Title:
Triglyceride-Glucose Index and Diabetic Vascular Disease
文章编号:
202109049
作者:
蔡薇 杨堰焯 刘昊凌
(哈尔滨医科大学附属第一医院内分泌科,黑龙江 哈尔滨 150001)
Author(s):
CAI Wei; YANG Yanzhuo;  LIU Haoling
(Department of Endocrinology,The First Affiliated Hospital of Harbin Medical University,Harbin 150001,Heilongjiang,China)
关键词:
甘油三酯葡萄糖乘积指数; 胰岛素抵抗; 2型糖尿病; 动脉粥样硬化性心血管疾病; 糖尿病微血管病变
Keywords:
Triglyceride-glucose index; Insulin resistance; Type?2?diabetes; Atherosclerotic cardiovascular disease; Diabetic microvascular complication
DOI:
10.16806/j.cnki.issn.1004-3934.2022.03.000
摘要:
胰岛素抵抗是2型糖尿病发病的重要原因之一，是导致心血管疾病、代谢综合征和其他共病代谢改变的来源。因此，胰岛素抵抗的早期诊断至关重要。血清甘油三酯葡萄糖乘积指数为一种新型胰岛素抵抗替代指标，现就其在2型糖尿病及糖尿病血管病变的研究进展做一综述。
Abstract:
Insulin resistance is one of the important causes of type?2?diabetes and it is the origin of the metabolic alterations that lead to the development of cardiovascular diseases,metabolic syndrome and other comorbidities. Therefore,the early diagnosis of insulin resistance is very important. The serum triglyceride-glucose index is a new index of insulin resistance,and its research progress in type 2 diabetes and diabetic vascular disease is reviewed in this article

相似文献/References:

[1]陈炜,许贞蓉.表观遗传学与代谢性心血管疾病的研究进展[J].心血管病学进展,2019,(6):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
　CHEN Wei,XU Zhenrong.Epigenetics and Cardiometabolic Disease[J].Advances in Cardiovascular Diseases,2019,(3):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
[2]占小锋 张长磊 李刚.β肾上腺素受体阻滞剂对甘油三酯代谢的影响及其作用机制的阐述[J].心血管病学进展,2019,(9):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
　ZHAN Xiaofeng,ZHANG Changlei,LI Gang.Effect of -adrenergic Receptor Blockers on Triglyceride Metabolism and Mechanism[J].Advances in Cardiovascular Diseases,2019,(3):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
[3]李莎 熊峰.胰岛素抵抗与心血管疾病研究进展[J].心血管病学进展,2019,(9):1307.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.032]
　Li ShaXiong Feng.Insulin Resistance and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(3):1307.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.032]
[4]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
　WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(3):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[5]任蕾 夏芳芳 戴红艳.血管生成素样蛋白6在心血管病方面的研究进展[J].心血管病学进展,2020,(4):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
　REN Lei,XIA FangFang,DAI HongYan.Relationship Between ANGPTL6 and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(3):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
[6]杨晓倩 秦莉 张艺文 童兰 汪汉.糖皮质激素与心血管疾病[J].心血管病学进展,2020,(4):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
　YANG Xiaoqian,QIN Li,ZHANG Yiwen,et al.Glucocorticoid and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(3):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
[7]樊德慧 金娟 韩宇博 田苗 刘莉.利钠肽与代谢综合征的研究进展[J].心血管病学进展,2020,(10):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
　FAN Dehui,JIN Juan,HAN Yubo,et al.Research Progress of Natriuretic Peptide and Metabolic Syndrome[J].Advances in Cardiovascular Diseases,2020,(3):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
[8]王晓琪 苏冠华.高尿酸血症和心力衰竭的病理生理机制、治疗和预后价值[J].心血管病学进展,2021,(9):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
　WANG Xiaoqi,SU Guanhua.Pathophysiological Mechanism, Treatment and Prognostic Value of Hyperuricemia and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(3):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[9]谭思华 周晓莉.非酒精性脂肪肝与冠状动脉粥样硬化及炎症的研究进展[J].心血管病学进展,2023,(5):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]
　TAN Sihua,ZHOU Xiaoli.Association of Non-Alcoholic Fatty Liver Disease with Coronary Atherosclerosis and Inflammation[J].Advances in Cardiovascular Diseases,2023,(3):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]
[10]徐明成 赵玉娟.甘油三酯葡萄糖指数对动脉粥样硬化性心血管疾病的预测价值[J].心血管病学进展,2023,(9):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
　Xu Mingcheng,ZHAO Yujuan.Predictive Value of Triglyceride Glucose Index in Atherosclerotic Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2023,(3):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
[11]廖丽萍 周跟东 张晓红.血清甘油三酯葡萄糖乘积指数与代谢性疾病的研究进展[J].心血管病学进展,2020,(11):1189.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[12]魏罗嫚,杨玉亭,和丽丽,等.甘油三酯葡萄糖乘积指数在心力衰竭中的研究进展[J].心血管病学进展,2023,(8):724.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.012]
　WEI Luoman,YANG Yuting,HE Lili,et al.Advances of Triglyceride Glucose Index in Heart Failure[J].Advances in Cardiovascular Diseases,2023,(3):724.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.012]

更新日期/Last Update: 2022-04-20